Anika Therapeutics Inc (ANIK)

CapEx to Revenue

4.44%

Quarterly · Period ending:

ANIK logo

ANIK CapEx to Revenue

Latest reported4.44%
ANIK Quarterly CapEx/Revenue (0.00% → 4.44%)
High-resolution chart · PNG

ANIK capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
4.4434%
4.8325%
2.1166%
6.7836%
5.1986%
10.7918%
-101.3178%
4.6861%
11.076%
4.4617%
4.282%
1.787%
3.2888%
3.6626%
6.3828%
4.1998%
4.8919%
3.6138%
3.1462%
3.2477%
6.0689%
1.216%
1.3736%
0.8551%
0.603%
2.0425%
0.9002%
1.4412%
3.6196%
4.1662%
0.6047%
4.5171%
2.4224%
11.9592%
8.4184%
9.524%
6.7001%
7.1624%
4.8945%
10.6208%
12.983%
28.8022%
23.2955%
3.7756%
3.8333%
1.6496%
2.7212%
1.1007%
1.5256%
0.813%
0.9651%
0.7093%
0.3556%
0.2348%
0.9388%
0.9954%
4.6953%
1.5602%
2.4202%
1.6156%
3.5885%
0.6523%
6.5704%
5.8072%
1.5642%
6.301%
5.1927%
7.8295%
13.621%
13.7885%
15.3033%
35.4992%
88.8663%
41.588%
88.5265%
43.108%
30.149%
10.7366%
2.4241%
2.1125%
8.538%
5.2676%
9.4402%
7.5363%
3.7179%
0.8915%
0.7053%
2.9967%
1.2616%
2.4263%
1.795%
0.8948%
1.1151%
2.8369%
0.3308%
1.0215%
0.7986%
0.6222%
1.3736%
7.8166%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.